Cargando…

Landscape of enhancer disruption and functional screen in melanoma cells

BACKGROUND: The high mutation rate throughout the entire melanoma genome presents a major challenge in stratifying true driver events from the background mutations. Numerous recurrent non-coding alterations, such as those in enhancers, can shape tumor evolution, thereby emphasizing the importance in...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Zhao, Luo, Menghan, Liang, Qian, Zhao, Ke, Hu, Yuelin, Wang, Wei, Feng, Xiangling, Hu, Bolang, Teng, Jianjin, You, Tianyi, Li, Ran, Bao, Zhengkai, Pan, Wenhao, Yang, Tielong, Zhang, Chao, Li, Ting, Dong, Xiaobao, Yi, Xianfu, Liu, Ben, Zhao, Li, Li, Miaoxin, Chen, Kexin, Song, Weihong, Yang, Jilong, Li, Mulin Jun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10614365/
https://www.ncbi.nlm.nih.gov/pubmed/37904237
http://dx.doi.org/10.1186/s13059-023-03087-5
_version_ 1785129013910437888
author Wang, Zhao
Luo, Menghan
Liang, Qian
Zhao, Ke
Hu, Yuelin
Wang, Wei
Feng, Xiangling
Hu, Bolang
Teng, Jianjin
You, Tianyi
Li, Ran
Bao, Zhengkai
Pan, Wenhao
Yang, Tielong
Zhang, Chao
Li, Ting
Dong, Xiaobao
Yi, Xianfu
Liu, Ben
Zhao, Li
Li, Miaoxin
Chen, Kexin
Song, Weihong
Yang, Jilong
Li, Mulin Jun
author_facet Wang, Zhao
Luo, Menghan
Liang, Qian
Zhao, Ke
Hu, Yuelin
Wang, Wei
Feng, Xiangling
Hu, Bolang
Teng, Jianjin
You, Tianyi
Li, Ran
Bao, Zhengkai
Pan, Wenhao
Yang, Tielong
Zhang, Chao
Li, Ting
Dong, Xiaobao
Yi, Xianfu
Liu, Ben
Zhao, Li
Li, Miaoxin
Chen, Kexin
Song, Weihong
Yang, Jilong
Li, Mulin Jun
author_sort Wang, Zhao
collection PubMed
description BACKGROUND: The high mutation rate throughout the entire melanoma genome presents a major challenge in stratifying true driver events from the background mutations. Numerous recurrent non-coding alterations, such as those in enhancers, can shape tumor evolution, thereby emphasizing the importance in systematically deciphering enhancer disruptions in melanoma. RESULTS: Here, we leveraged 297 melanoma whole-genome sequencing samples to prioritize highly recurrent regions. By performing a genome-scale CRISPR interference (CRISPRi) screen on highly recurrent region-associated enhancers in melanoma cells, we identified 66 significant hits which could have tumor-suppressive roles. These functional enhancers show unique mutational patterns independent of classical significantly mutated genes in melanoma. Target gene analysis for the essential enhancers reveal many known and hidden mechanisms underlying melanoma growth. Utilizing extensive functional validation experiments, we demonstrate that a super enhancer element could modulate melanoma cell proliferation by targeting MEF2A, and another distal enhancer is able to sustain PTEN tumor-suppressive potential via long-range interactions. CONCLUSIONS: Our study establishes a catalogue of crucial enhancers and their target genes in melanoma growth and progression, and illuminates the identification of novel mechanisms of dysregulation for melanoma driver genes and new therapeutic targeting strategies. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s13059-023-03087-5.
format Online
Article
Text
id pubmed-10614365
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-106143652023-10-31 Landscape of enhancer disruption and functional screen in melanoma cells Wang, Zhao Luo, Menghan Liang, Qian Zhao, Ke Hu, Yuelin Wang, Wei Feng, Xiangling Hu, Bolang Teng, Jianjin You, Tianyi Li, Ran Bao, Zhengkai Pan, Wenhao Yang, Tielong Zhang, Chao Li, Ting Dong, Xiaobao Yi, Xianfu Liu, Ben Zhao, Li Li, Miaoxin Chen, Kexin Song, Weihong Yang, Jilong Li, Mulin Jun Genome Biol Research BACKGROUND: The high mutation rate throughout the entire melanoma genome presents a major challenge in stratifying true driver events from the background mutations. Numerous recurrent non-coding alterations, such as those in enhancers, can shape tumor evolution, thereby emphasizing the importance in systematically deciphering enhancer disruptions in melanoma. RESULTS: Here, we leveraged 297 melanoma whole-genome sequencing samples to prioritize highly recurrent regions. By performing a genome-scale CRISPR interference (CRISPRi) screen on highly recurrent region-associated enhancers in melanoma cells, we identified 66 significant hits which could have tumor-suppressive roles. These functional enhancers show unique mutational patterns independent of classical significantly mutated genes in melanoma. Target gene analysis for the essential enhancers reveal many known and hidden mechanisms underlying melanoma growth. Utilizing extensive functional validation experiments, we demonstrate that a super enhancer element could modulate melanoma cell proliferation by targeting MEF2A, and another distal enhancer is able to sustain PTEN tumor-suppressive potential via long-range interactions. CONCLUSIONS: Our study establishes a catalogue of crucial enhancers and their target genes in melanoma growth and progression, and illuminates the identification of novel mechanisms of dysregulation for melanoma driver genes and new therapeutic targeting strategies. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s13059-023-03087-5. BioMed Central 2023-10-30 /pmc/articles/PMC10614365/ /pubmed/37904237 http://dx.doi.org/10.1186/s13059-023-03087-5 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Wang, Zhao
Luo, Menghan
Liang, Qian
Zhao, Ke
Hu, Yuelin
Wang, Wei
Feng, Xiangling
Hu, Bolang
Teng, Jianjin
You, Tianyi
Li, Ran
Bao, Zhengkai
Pan, Wenhao
Yang, Tielong
Zhang, Chao
Li, Ting
Dong, Xiaobao
Yi, Xianfu
Liu, Ben
Zhao, Li
Li, Miaoxin
Chen, Kexin
Song, Weihong
Yang, Jilong
Li, Mulin Jun
Landscape of enhancer disruption and functional screen in melanoma cells
title Landscape of enhancer disruption and functional screen in melanoma cells
title_full Landscape of enhancer disruption and functional screen in melanoma cells
title_fullStr Landscape of enhancer disruption and functional screen in melanoma cells
title_full_unstemmed Landscape of enhancer disruption and functional screen in melanoma cells
title_short Landscape of enhancer disruption and functional screen in melanoma cells
title_sort landscape of enhancer disruption and functional screen in melanoma cells
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10614365/
https://www.ncbi.nlm.nih.gov/pubmed/37904237
http://dx.doi.org/10.1186/s13059-023-03087-5
work_keys_str_mv AT wangzhao landscapeofenhancerdisruptionandfunctionalscreeninmelanomacells
AT luomenghan landscapeofenhancerdisruptionandfunctionalscreeninmelanomacells
AT liangqian landscapeofenhancerdisruptionandfunctionalscreeninmelanomacells
AT zhaoke landscapeofenhancerdisruptionandfunctionalscreeninmelanomacells
AT huyuelin landscapeofenhancerdisruptionandfunctionalscreeninmelanomacells
AT wangwei landscapeofenhancerdisruptionandfunctionalscreeninmelanomacells
AT fengxiangling landscapeofenhancerdisruptionandfunctionalscreeninmelanomacells
AT hubolang landscapeofenhancerdisruptionandfunctionalscreeninmelanomacells
AT tengjianjin landscapeofenhancerdisruptionandfunctionalscreeninmelanomacells
AT youtianyi landscapeofenhancerdisruptionandfunctionalscreeninmelanomacells
AT liran landscapeofenhancerdisruptionandfunctionalscreeninmelanomacells
AT baozhengkai landscapeofenhancerdisruptionandfunctionalscreeninmelanomacells
AT panwenhao landscapeofenhancerdisruptionandfunctionalscreeninmelanomacells
AT yangtielong landscapeofenhancerdisruptionandfunctionalscreeninmelanomacells
AT zhangchao landscapeofenhancerdisruptionandfunctionalscreeninmelanomacells
AT liting landscapeofenhancerdisruptionandfunctionalscreeninmelanomacells
AT dongxiaobao landscapeofenhancerdisruptionandfunctionalscreeninmelanomacells
AT yixianfu landscapeofenhancerdisruptionandfunctionalscreeninmelanomacells
AT liuben landscapeofenhancerdisruptionandfunctionalscreeninmelanomacells
AT zhaoli landscapeofenhancerdisruptionandfunctionalscreeninmelanomacells
AT limiaoxin landscapeofenhancerdisruptionandfunctionalscreeninmelanomacells
AT chenkexin landscapeofenhancerdisruptionandfunctionalscreeninmelanomacells
AT songweihong landscapeofenhancerdisruptionandfunctionalscreeninmelanomacells
AT yangjilong landscapeofenhancerdisruptionandfunctionalscreeninmelanomacells
AT limulinjun landscapeofenhancerdisruptionandfunctionalscreeninmelanomacells